Infection Pharmacology Research
The Infection Pharmacology group at the Institute of Translational Medicine at the University of Liverpool is undertaking work in pharmacology of HIV, hepatitis and TB.
Find out more
https://www.liverpool.ac.uk/translational-medicine/research/infection-pharmacology/about/
HIV and HCV Drug Interactions websites
The HCV and HIV Drug Interactions website seek to monitor drug interaction data in HIV and viral hepatitis and inform where there are no data. The team, based at the University of Liverpool is responsible for constantly monitoring and updating the website content. Both sites Liverpool HIV are owned by the University of Liverpool, and operate as not-for-profit, with the following mission:
To provide a clinically useful, reliable, comprehensive, up-to-date, evidence-based drug-drug interaction resource, freely available to healthcare workers, patients and researchers.
http://www.hep-druginteractions.org/
http://www.hiv-druginteractions.org/
HIV Nanomedicines
According to recent numbers released by UNAIDS, up to 42.9 million people are living with HIV, but only 19.5 million people around the world have access to antiretroviral therapy.
Pioneering collaborative interdisciplinary research projects led by the University of Liverpool aims to reduce this gap through the use of nanotechnology.
Find out more
https://www.liverpool.ac.uk/research/our-research/advanced-materials/nanomedicine/
